Open access · OA
via Europe PMC
Taurine bolsters adoptive T cell therapy efficacy against hepatocellular carcinoma by reprogramming T cell function.
Zhang Z, Li S, Li M, Gong L, Lu X, Xu W, Chen AA, Wang Y, He C, Mo G, Xie Y, Yue SA, Huang L, Yang C, Hou J
Cancer immunology, immunotherapy : CII · 2026
Mitochondrial dysfunction
Altered intercellular communication
Partial reprogramming (OSK)
Cell culture / in vitro
In vitro
Abstract
Adoptive T cell therapy for advanced hepatocellular carcinoma (HCC) is limited by the immunosuppressive tumor microenvironment, which impairs T-cell function. Overcoming this immunosuppression and restoring T-cell functionality are crucial for improving therapeutic efficacy. Here, we investigated the role of taurine in regulating alpha-fetoprotein (AFP)-specific T-cell receptor-engineered T cells (TCR-T) function. Metabolomic profiling revealed that intracellular taurine levels declined during the early phase of T-cell activation, while expression of the taurine transporter SLC6A6 increased over time. In addition, taurine abundance was lower in HCC tissues than in normal liver tissues in vivo, suggesting that taurine availability is reduced during both T-cell activation and tumor progression. Functionally, taurine supplementation enhanced the cytotoxic activity, persistence, and intratumoral infiltration of AFP-specific TCR-T, while reducing exhaustion and apoptosis after repetitive tumor stimulation. In contrast, taurine-limited conditions impaired T-cell proliferation and survival, attenuated antitumor activity in vitro and in vivo, and promoted an exhaustion-prone phenotype. Taurine supplementation also partially restored the function of β-alanine-preconditioned T cells. Mechanistically, transcriptomic and proteomic analyses identified PI3K-AKT signaling as a key pathway associated with taurine-mediated T-cell regulation. Taurine-limited T cells showed reduced AKT phosphorylation and developed a metabolically stressed state characterized by increased mitochondrial respiration, glycolytic activity, reactive oxygen species production and mitochondrial structural abnormalities during activation. Together, these findings identify taurine availability as an important metabolic regulator of engineered T-cell fitness and support taurine-based metabolic conditioning as a potential strategy to improve TCR-T therapy for HCC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s00262-026-04503-y
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Z, Z., S, L., M, L., L, G., X, L., W, X., AA, C., Y, W., C, H., G, M., Y, X., SA, Y., L, H., C, Y., J, H., & W., Z. (2026). Taurine bolsters adoptive T cell therapy efficacy against hepatocellular carcinoma by reprogramming T cell function. <em>Cancer immunology, immunotherapy : CII</em>. https://doi.org/10.1007/s00262-026-04503-y
Vancouver
Z Z, S L, M L, L G, X L, W X, et al. Taurine bolsters adoptive T cell therapy efficacy against hepatocellular carcinoma by reprogramming T cell function. Cancer immunology, immunotherapy : CII. 2026. doi:10.1007/s00262-026-04503-y.
BibTeX
@article{zhang2026Taurin,
title = {Taurine bolsters adoptive T cell therapy efficacy against hepatocellular carcinoma by reprogramming T cell function.},
author = {Zhang Z and Li S and Li M and Gong L and Lu X and Xu W and Chen AA and Wang Y and He C and Mo G and Xie Y and Yue SA and Huang L and Yang C and Hou J and Zhu W.},
journal = {Cancer immunology, immunotherapy : CII},
year = {2026},
doi = {10.1007/s00262-026-04503-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Communication and Signaling 2026
Open access · CC-BY
Taurine preserves γδ T cell fitness in triple-negative breast cancer
biorxiv 2024
Preprint · CC-BY
Nifuroxazide Suppresses PD-L1 Expression and Enhances the Efficacy of Radiotherapy in Hepatocellular Carcinoma
Molecular Medicine Reports 2017
Open access · CC-BY
Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells
Acta Pharmacologica Sinica 2015
Open access · CC-BY
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
TSpace (University of Toronto) 2018
Preprint · OA
Generation of induced progenitor-like (iPL) cells using interrupted reprogramming
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY